Cashu | News | ATAI

HomeWatchlistNewsSignalsPicks

DJI

-1.23%

SPX

-1.60%

IXIC

-2.24%

FTSE

-0.70%

N225

-0.66%

AXJO

-0.92%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest ATAI Life Sciences N.V. News

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Feature Image for interests on Big Losers, Consumer Defensive, Financial Services, Markets from benzinga.com

US Stocks Likely To Open Higher As US-EU Ink Trade Deal: Tesla, Palantir, UnitedHealth In Focus

Feature Image for interests on Basic Materials, Consumer Cyclical, Consumer Defensive, Energy from benzinga.com

Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday

Feature Image for interests on Big Gainers, Consumer Cyclical, Consumer Defensive, Consumer Discretionary from benzinga.com

about 1 month ago

Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data

Feature Image for interests on Briefs, Cannabis, Consumer Defensive, News from benzinga.com

about 1 month ago

CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

about 2 months ago

AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth

Feature Image for interests on Atai, Atai Life Sciences, Beckley Psytech, Benzinga from benzinga.com

Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes

Feature Image for interests on Atai, Benzinga, Cannabis, Cmps from benzinga.com

Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies

Feature Image for interests on Atai, Atai Life Sciences, Benzinga, Cannabis from benzinga.com

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

Feature Image for interests on Atai, Atai Life Sciences, Awakn Life Sciences, Awaknf from benzinga.com

Stocks

Health Care

atai

ATAI Life Sciences N.V.

NASDAQ: ATAI

+0.07 (+1.71%)

4.17

USD

At close at Aug 01, 20:40 UTC

Latest Cashu News

ATAI Life Sciences N.V.: Pioneering the Future of Psychedelic Medicine and Mental Health Treatment

ATAI Life Sciences Leads Psychedelic Research Amid Growing Market Optimism for Mental Health Solutions

ATAI Life Sciences N.V. Advances Psychedelic Research for Treatment-Resistant Depression with BPL-003